Prostate Cancer News and Research

Latest Prostate Cancer News and Research

Did your doctor ‘ghost’ you? An employment contract may be to blame

When Don Cue developed a bladder infection last fall, he called his longtime urologist's office for a urine culture and antibiotics. It was a familiar routine for the two-time prostate cancer survivor; infections were not uncommon since he began using a catheter that connects to his bladder through an incision in his abdomen.

19 Mar 2019

Hormonal treatment associated with depression in men with prostate cancer

Men who receive anti-hormonal treatment after having their prostate removed are 80% more likely to suffer from depression than men who don't receive this treatment. This leads researchers to suggest that patients receiving androgen deprivation therapy should be monitored for post-surgical depression.

18 Mar 2019

Compounds found in coffee may inhibit growth of prostate cancer

For the first time, scientists have identified compounds found in coffee which may inhibit the growth of prostate cancer. This is a pilot study, carried out on drug-resistant cancer cells in cell culture and in a mouse model; it has not yet been tested in humans.

18 Mar 2019

Testosterone treatment lowers recurrence rates in low-risk prostate cancer patients

In the largest such study so far undertaken, US researchers have shown that testosterone replacement slows the recurrence of prostate cancer in low-risk patients.

18 Mar 2019

Prostate cancer treatment breakthrough

Researchers have developed a method by which thousands of men with prostate cancer could choose their own treatment.

13 Mar 2019

New risk model can predict survival of non-metastatic prostate cancer patients

A new risk model, easily accessible on a web interface, can predict the survival of non-metastatic prostate cancer patients, as well as the effect of different treatment approaches on survival.

13 Mar 2019

Nano therapy reverses deadliest effects of chronic kidney disease in animal model

By loading a chelation drug into a nano-sized homing device, researchers at Clemson University have reversed in an animal model the deadliest effects of chronic kidney disease, which kills more people in the United States each year than breast or prostate cancer.

5 Mar 2019

Miniature tumor organoids could help guide treatment decisions for people with rare cancers

UCLA scientists have developed a new method to quickly screen hundreds of drugs in order to identify treatments that can target specific tumors.

26 Feb 2019

Lack of diversity in cell lines does not allow minorities to reap the benefits of precision medicine

As the biomedical field races to develop therapies based on an individual's genetic makeup, a City of Hope scientist and his colleagues found that some commercial cell lines used for countless laboratory studies have mislabeled ancestry when it comes to minorities.

25 Feb 2019

CPRIT awards nearly $20 million to The University of Texas MD Anderson Cancer Center

The University of Texas MD Anderson Cancer Center today was awarded $19.6 million from the Cancer Prevention and Research Institute of Texas (CPRIT) to support research, recruitment and prevention efforts.

22 Feb 2019

H-RT should be the standard of care for men with low risk prostate cancer, study shows

Results from the NRG Oncology clinical study NRG-RTOG 0415 determined that a hypofractionated radiotherapy schedule, a treatment schedule that delivers a total dose of radiotherapy over a shorter period of time, is not worse than the conventional radiotherapy schedule in terms of bowel, bladder, sexual, and general quality of life as well as anxiety and depression for men with low risk prostate cancer.

15 Feb 2019

Racial disparities in cancer deaths on the decline for America

A new report has concluded that the racial disparities between cancer deaths among white and black Americans is on the decline.

15 Feb 2019

Castration-resistant metastatic prostate cancer responds to combination of immune checkpoint inhibitors

Some patients with metastatic prostate cancer respond to a combination of immune checkpoint inhibitors after hormonal therapy and chemotherapy have failed, according to early results from a clinical trial led by investigators at The University of Texas MD Anderson Cancer Center presented today at the American Society of Clinical Oncology Genitourinary Cancers Symposium in San Francisco.

15 Feb 2019

Few primary care physicians lack enough knowledge of cancer treatment options

The idea of team-based cancer care most often focuses on involving primary care physicians in the care of cancer survivors. But research has shown patients are discussing initial cancer treatment options with their primary care doctors.

13 Feb 2019

Watchful waiting in prostate cancer becoming more popular

In 2010, the US National Comprehensive Cancer Network guidelines suggested that patients with stable and low-risk prostate cancers could be managed with active surveillance or watchful waiting (AS/WW). AS/WW was considered to be a safe and effective alternative to aggressive surgery to remove the prostate and radiation therapy.

11 Feb 2019

Trojan Horse approach to cancer therapy shows promise

A new form of cancer fighting drug has been developed using the principles of the “Trojan Horse”.

11 Feb 2019

Immunotherapy may be better than chemotherapy for Merkel cell carcinoma

The first study of the immunotherapy drug pembrolizumab as the initial treatment for patients with a rare but aggressive form of skin cancer known as Merkel cell carcinoma reports better responses and longer survival than expected with conventional chemotherapy.

11 Feb 2019

Stereotactic body radiotherapy effective in treating men with low- or intermediate-risk prostate cancer

A new UCLA-led study shows that men with low- or intermediate-risk prostate cancer can safely undergo higher doses of radiation over a significantly shorter period of time and still have the same, successful outcomes as from a much longer course of treatment.

11 Feb 2019

New cancer drug that acts as ‘Trojan horse’ shows promise in patients with various cancers

A brand new type of cancer drug that acts as a 'Trojan horse' to get inside tumor cells has shown promise in patients with six different cancer types.

11 Feb 2019

Study identifies fatty acids as important fuel source for prostate tumors

An international multidisciplinary study initiated by Melbourne scientists has shown a link between prostate cancer and the uptake of fatty acids by cancer cells.

8 Feb 2019

Prostate Cancer News and Research

Latest Prostate Cancer News and Research

Did your doctor ‘ghost’ you? An employment contract may be to blame

Hormonal treatment associated with depression in men with prostate cancer

Compounds found in coffee may inhibit growth of prostate cancer

Testosterone treatment lowers recurrence rates in low-risk prostate cancer patients

Prostate cancer treatment breakthrough

New risk model can predict survival of non-metastatic prostate cancer patients

Nano therapy reverses deadliest effects of chronic kidney disease in animal model

Miniature tumor organoids could help guide treatment decisions for people with rare cancers

Lack of diversity in cell lines does not allow minorities to reap the benefits of precision medicine

CPRIT awards nearly $20 million to The University of Texas MD Anderson Cancer Center

H-RT should be the standard of care for men with low risk prostate cancer, study shows

Racial disparities in cancer deaths on the decline for America

Castration-resistant metastatic prostate cancer responds to combination of immune checkpoint inhibitors

Few primary care physicians lack enough knowledge of cancer treatment options

Watchful waiting in prostate cancer becoming more popular

Trojan Horse approach to cancer therapy shows promise

Immunotherapy may be better than chemotherapy for Merkel cell carcinoma

Stereotactic body radiotherapy effective in treating men with low- or intermediate-risk prostate cancer

New cancer drug that acts as ‘Trojan horse’ shows promise in patients with various cancers

Study identifies fatty acids as important fuel source for prostate tumors

What to know about prostate cancer eBook

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Scalable, Smart, and Accessible: The Future of Lab Automation

Healthy Beginnings, Hopeful Futures: A Conversation with WHO’s Dr. Allotey

Prostate Cancer News and Research

Latest Prostate Cancer News and Research

What to know about prostate cancer eBook

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Scalable, Smart, and Accessible: The Future of Lab Automation

Healthy Beginnings, Hopeful Futures: A Conversation with WHO’s Dr. Allotey

Newsletters you may be interested in